A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

Ignacio Basurte-Villamor,1 Pablo Vega,2 Carlos Roncero,3– 5 José Martínez-Raga,6 Lara Grau-López,7– 10 Lourdes Aguilar,3– 5 Marta Torrens,11 Nestor Szerman12 1Department of Psychiatry and Behavioral Health, Clínica López Ibor, Madrid, Spain; 2Institute for Addictions, Madrid Salud, Madrid City Counc...

Full description

Bibliographic Details
Main Authors:	Basurte-Villamor I, Vega P, Roncero C, Martínez-Raga J, Grau-López L, Aguilar L, Torrens M, Szerman N
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-05-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	vortioxetine major depressive disorder substance use disorder dual disorder major dual depressive disorder real-world evidence
Online Access:	https://www.dovepress.com/a-feasibility-study-of-patients-with-major-depression-and-substance-us-peer-reviewed-fulltext-article-NDT

Similar Items

Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
by: McIntyre RS, et al.
Published: (2021-02-01)

Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
by: Inoue T, et al.
Published: (2021-12-01)

Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
by: Djamila Bennabi, et al.
Published: (2019-11-01)

Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study
by: De Filippis S, et al.
Published: (2022-08-01)

Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study
by: Gregory Mattingly, et al.
Published: (2023-01-01)

Vortioxetine usage in an elderly patient with major depressive disorder and accompanied by multiple physical conditions: A case report
by: Xiaoman Wang, et al.
Published: (2023-12-01)

Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
by: Wang G, et al.
Published: (2022-08-01)

Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study
by: Polosan M, et al.
Published: (2022-08-01)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
by: Bing Cao, et al.
Published: (2019-01-01)

Comparison of the efficacy of the multimodal serotonergic antidepressants trazodone and vortioxetine in the treatment of patients with endogenous depression: A meta-analysis of double-blind randomized placebo-controlled trials
by: D. S. Danilov
Published: (2017-03-01)

Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults
by: Xinyan Zhang, et al.
Published: (2022-06-01)

Health-Related Quality of Life in Male Patients under Treatment for Substance Use Disorders with and without Major Depressive Disorder: Influence in Clinical Course at One-Year Follow-Up
by: Julia E. Marquez-Arrico, et al.
Published: (2020-09-01)

Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders
by: Julia E. Marquez-Arrico, et al.
Published: (2022-11-01)

Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer’s disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea
by: Eduardo Cumbo, et al.
Published: (2023-01-01)

Circadian Characteristics in Patients under Treatment for Substance Use Disorders and Severe Mental Illness (Schizophrenia, Major Depression and Bipolar Disorder)
by: Ana Belén Serrano-Serrano, et al.
Published: (2021-09-01)

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
by: Eugenia Papalexi, et al.
Published: (2022-08-01)

Vortioxetine Modulates the Regional Signal in First-Episode Drug-Free Major Depressive Disorder at Rest
by: Shihong Xiong, et al.
Published: (2022-06-01)

Cognitive impairment in depression: recent advances and novel treatments
by: Perini G, et al.
Published: (2019-05-01)

Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
by: Domenico De Berardis, et al.

Circadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder
by: Iman Hashemzadeh, et al.
Published: (2021-10-01)

Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
by: Célia Fourrier, et al.
Published: (2018-08-01)

An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
by: Anish Shah, et al.
Published: (2018-05-01)

Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea
by: Seok Woo Moon, et al.
Published: (2023-03-01)

Therapeutic management of major depression and psoriazis dual diagnosis
by: O. Vasiliu
Published: (2021-04-01)

Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
by: Marcin Siwek, et al.
Published: (2022-03-01)

Serious mental illness and negative substance use consequences among adults on probation
by: Matthew E. Rossheim, et al.
Published: (2018-03-01)

Protocol for Characterization of Addiction and Dual Disorders: Effectiveness of Coadjuvant Chronotherapy in Patients with Partial Response
by: Ana Adan, et al.
Published: (2022-03-01)

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
by: Yoshimura R, et al.
Published: (2021-04-01)

Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use
by: Ana Adan, et al.
Published: (2017-10-01)

Effectiveness of vortioxetine for winter depression in bipolar disorder: A case report
by: Yusei Yamaguchi, et al.
Published: (2024-03-01)

Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trialResearch in context
by: Giovanni Ostuzzi, et al.
Published: (2024-03-01)

Prevalence of substance use disorders among patients with systemic lupus erythematous and major depressive disorder
by: Kevin J. Varghese, et al.
Published: (2023-12-01)

Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder
by: Kato M, et al.
Published: (2024-01-01)

Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study
by: Brandon T. McDaniel, et al.
Published: (2023-12-01)

The Effectiveness of Group Dialectical Behavior Therapy Method on Major Depression in Individuals Referred to Residential and Semi-Residential Addiction Recovery Centers
by: Mohammad Malekzadeh, et al.
Published: (2018-05-01)

Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
by: Cristina Segura-Garcia, et al.
Published: (2021-03-01)

What patients with bipolar disorder and major depressive disorder perceive as adverse life events precipitating a current major depressive episode
by: Robyn Anne van Schoor, et al.
Published: (2015-05-01)

Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental)
by: D. Bennabi, et al.
Published: (2019-01-01)

The efficacy of vortioxetine for the delusional disorder of cenesthopathy
by: Shinji Sato, et al.
Published: (2024-03-01)

Relationships between GAT1 and PTSD, Depression, and Substance Use Disorder
by: Kaitlin E. Bountress, et al.
Published: (2017-01-01)